IP Library Granted Patent US 8,637,669
Granted Patent B2
US 8,637,669 · App. 13/119,538 · Granted Jan 28, 2014

Production method for adefovir dipivoxil

Inventors: Kwang Do Choi (Anyang-si, KR); Yong Tack Lee (Seoul, KR); Myeong Sik Yoon (Yongin-si, KR); Hye Suk Hong (Seongnam-si, KR); Il Hwan Cho (Seoul, KR); Si Beum Lee (Yongin-si, KR); Seong Cheol Bang (Nonsan-si, KR); Da Won Oh (Seoul, KR); Min Kyoung Lee (Yongin-si, KR)
Assignee: CJ Cheiljedang Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,637,669
App. No.
13/119,538
Granted
Jan 28, 2014
Kind
B2
Abstract

The present invention relates to an improved method of preparing adefovir dipivoxil of Formula 1. The method of the present invention is characterized by using dimethylsulfoxide as a reaction solvent, and comprises a process of preparing adefovir dipivoxil of Formula 1 by allowing adefovir of Formula 2 to react with chloromethylpivalate at a reaction temperature of 30 to 50° C. under the presence of dimethylsulfoxide and triethylamine solvents.

Claims (7)

1. A method of preparing adefovir dipivoxil of Formula 1, comprising the step of reacting adefovir of Formula 2 with chloromethylpivalate under the presence of dimethylsulfoxide and triethylamine solvents:

2. The method of claim 1 , wherein the prepared adefovir dipivoxil of Formula 1 contains 15% or less of byproducts of Formula 3:

3. The method of claim 1 , wherein the reaction is carried out at a temperature of 30 to 50° C.

4. The method of any one of claims 1 to 3 , wherein the reaction is carried out for 3 to 7 hours.

5. The method of any one of claims 1 to 3 , further comprising the step of purifying the prepared adefovir dipivoxil of Formula 1.

6. The method of claim 5 , wherein the purification step comprises the steps of dissolving the prepared adefovir dipivoxil of Formula 1 in water or a water-containing mixed solvent; purifying the adefovir dipivoxil solution through a reverse-phase column of which a stationary phase is hydrophobic; adding an organic solvent to the purified adefovir dipivoxil solution; and adding a base to the organic solvent-added solution.

7. The method of claim 6 , wherein the water-containing mixed solvent is a solvent in which water is dissolved in one or more solvents selected from the group consisting of C1 to C4 alcohol, acetone, acetonitrile, tetrahydrofuran, and dioxane in a concentration of 20 wt % or higher.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 2, 2014
From: CJ CHEILJEDANG CORPORATION
To: CJ HEALTHCARE CORPORATION
Reel/Frame 034305/0856 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 3, 2011
From: CHOI, KWANG DO; LEE, YONG TACK; YOON, MYEONG SIK; HONG, HYE SUK; CHO, IL HWAN; LEE, SI BEUM; BANG, SEONG CHEOL; OH, DA WON; LEE, MIN KYOUNG
To: CJ CHEILJEDANG CORPORATION
Reel/Frame 026216/0173 →
Priority Claims (2)
KR 10-2008-0091390 · Sep 18, 2008 · national
KR 10-2009-0001394 · Jan 8, 2009 · national
Continuity (1)
Related Publication 20110207930A1 · Aug 25, 2011